Skip to main content

Advertisement

ADVERTISEMENT

Department

News Connection
11/20/2016
A recently published review suggests that alternatives to inpatient hospitalization do not jeopardize the treatment of several acute medical conditions.
A recently published review suggests that alternatives to inpatient hospitalization do not jeopardize the treatment of several acute medical conditions.
A recently published review...
11/20/2016
First Report Managed Care

Advertisement

Managed Care Q&A
10/20/2016
An interview with Chad Johnson, senior vice president and executive director, Phoenix Children’s Care Network.
An interview with Chad Johnson, senior vice president and executive director, Phoenix Children’s Care Network.
An interview with Chad...
10/20/2016
First Report Managed Care
News Connection
10/20/2016
A group of Republican lawmakers are urging the Centers for Medicare and Medicaid Services (CMS) to revise its proposed implementation of the Medicare Access and CHIP Reauthorization Act, or MACRA, of 2015, which they argue would complicate...
A group of Republican lawmakers are urging the Centers for Medicare and Medicaid Services (CMS) to revise its proposed implementation of the Medicare Access and CHIP Reauthorization Act, or MACRA, of 2015, which they argue would complicate...
A group of Republican lawmakers...
10/20/2016
First Report Managed Care
News Connection
10/20/2016
An internal investigation by the US Department of Veterans’ Affairs (VA) found that the bloated budget and costly delays for construction of a new VA medical campus near Denver, Colorado were caused by gross mismanagement.
An internal investigation by the US Department of Veterans’ Affairs (VA) found that the bloated budget and costly delays for construction of a new VA medical campus near Denver, Colorado were caused by gross mismanagement.
An internal investigation by the...
10/20/2016
First Report Managed Care

Advertisement

News Connection
10/20/2016
According to recent research, for rheumatoid arthritis patients who have failed initial anti-tumor necrosis factor therapy, care providers should consider a non–TNF-targeted biologic due to a an effictive clinical response.
According to recent research, for rheumatoid arthritis patients who have failed initial anti-tumor necrosis factor therapy, care providers should consider a non–TNF-targeted biologic due to a an effictive clinical response.
According to recent research,...
10/20/2016
First Report Managed Care
News Connection
10/20/2016
Malnutrition associated with disease is responsible for more than $15.5 billion in direct medical costs each year, and is disproportionately driven by patients aged 65 years or older, according to an economic analysis recently published in...
Malnutrition associated with disease is responsible for more than $15.5 billion in direct medical costs each year, and is disproportionately driven by patients aged 65 years or older, according to an economic analysis recently published in...
Malnutrition associated with...
10/20/2016
First Report Managed Care
News Connection
10/20/2016
A recent analysis suggests myocardial infarction patients who were treated in health care institutions that demonstrated favorable 30-day risk-standardized mortality rates, also had longer life expectancies when compared to patients who were...
A recent analysis suggests myocardial infarction patients who were treated in health care institutions that demonstrated favorable 30-day risk-standardized mortality rates, also had longer life expectancies when compared to patients who were...
A recent analysis suggests...
10/20/2016
First Report Managed Care

Advertisement

News Connection
10/20/2016
Approximately 1 in 4 Americans reported worsened medical conditions after postponing an ED visit due to cost and insurance coverage concerns.
Approximately 1 in 4 Americans reported worsened medical conditions after postponing an ED visit due to cost and insurance coverage concerns.
Approximately 1 in 4 Americans...
10/20/2016
First Report Managed Care
News Connection
10/20/2016
The largest US health insurer, Anthem Inc, recently announced it would not cover the first FDA-approved Duchenne muscular dystrophy drug (DMD), Exondys 51 (eteplirsen; Sarepta Therapeutics) due to concerns over clinical trial data.
The largest US health insurer, Anthem Inc, recently announced it would not cover the first FDA-approved Duchenne muscular dystrophy drug (DMD), Exondys 51 (eteplirsen; Sarepta Therapeutics) due to concerns over clinical trial data.
The largest US health insurer,...
10/20/2016
First Report Managed Care
News Connection
10/20/2016
Inpatient drug costs rose 38.7% per admission between 2013 and 2015, according to a new analysis from the National Opinion Research Center at the University of Chicago.
Inpatient drug costs rose 38.7% per admission between 2013 and 2015, according to a new analysis from the National Opinion Research Center at the University of Chicago.
Inpatient drug costs rose 38.7%...
10/20/2016
First Report Managed Care

Advertisement

Advertisement